Diprophylline Pellets 479-18-5

Item Code:479-18-5 Features:In-house
  • Description
Diprophylline Pellets (Semi-finished products)
Specification:Enterprise Standard


It is an inhibitor to phosphodiesterase. It is used in the therapy of bronchial asthma, gasping bronchitis and gasping from cardiogenic pulmonary edema. It can soothe the symptom of gasping through loosening bronchial smooth muscle, increasing cardiac blood output, expanding kidney arteriole, increasing glomerulus filtration and renal blood flow, inhibiting distal end renal tubule’s reabsorption of sodion and chloridion, and increasing contractility of hanging skeletal muscle. Its action of expanding bronchus is only one tenth of that of aminophylline. It can easily be absorbed orally, metabolize to derivants of theophylline in vivo, and are excreted with urine.

Other Products

Product Name Cas No. Description
Product Name:
2,4-Dichloro-6,7-dimethoxyquinazoline
Model:
27631-29-4
Description:
98.5% Min
Product Name:
Daptomycin
Model:
103060-53-3
Description:
In-house
Product Name:
3,5-Diacetoxyacetophenone
Model:
35086-59-0
Description:
99%+
Product Name:
Deforolimus(Ridaforolimus)
Model:
572924-54-0
Description:
in-house
Product Name:
2,4-diamino-6-(hydroxymethyl)-pteridine
Model:
945-24-4
Description:
in-house
Product Name:
D-Mannose
Model:
3458-28-4
Description:
99%
Product Name:
1,4-Dioxane
Model:
123-91-1
Description:
99.5%+
Product Name:
Dirithromycin
Model:
62013-04-1
Description:
USP30/BP2000/EP6
more
Welcome to visit our booth(No.1935) on CPHI North America, Philadelphia during April 24-26th, 2018.